accession,experiment.accession,experiment.title,experiment.platform,experiment.instrument,study.accession,study.title,study.abstract,sample.accession,sample.title,sample.organism,sample.attributes.source_name,sample.attributes.cell line,sample.attributes.ENA-FIRST-PUBLIC,sample.attributes.ENA-LAST-UPDATE,title,files,sample.attributes.cell type,sample.attributes.genotype,sample.attributes.age,sample.attributes.Sex,sample.attributes.tissue,sample.attributes.ENA-SPOT-COUNT,sample.attributes.ENA-BASE-COUNT,sample.attributes.protocol,sample.attributes.location,sample.attributes.strain
SRR12507504,SRX8998538,Illumina HiSeq 2500 paired end sequencing; GSM4743488: 1_iPS; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251319,1_iPS,Homo sapiens,induced pluripotent stem cell,"Human iPS cell line, 1231A3",2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743488: 1_iPS; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/004/SRR12507504/SRR12507504.fastq.gz', 'md5': 'e1d61b64bf8d605e943364d49faccb0f', 'size': '20300987846'}]",,,,,,,,,,
SRR12507505,SRX8998539,Illumina HiSeq 2500 paired end sequencing; GSM4743489: 2_PSM; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251320,2_PSM,Homo sapiens,presomitic mesoderm,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743489: 2_PSM; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/005/SRR12507505/SRR12507505.fastq.gz', 'md5': '9126059e7f85742c8d7225e9e35a0c11', 'size': '19010223331'}]",iPS-derived presomitic mesoderm,,,,,,,,,
SRR12507506,SRX8998540,Illumina HiSeq 2500 paired end sequencing; GSM4743490: 3_SM; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251321,3_SM,Homo sapiens,somitic mesoderm,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743490: 3_SM; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/006/SRR12507506/SRR12507506.fastq.gz', 'md5': '3fcb4bb72ded9710b402c717bcaffba4', 'size': '19437371422'}]",iPS-derived somitic mesoderm,,,,,,,,,
SRR12507507,SRX8998541,Illumina HiSeq 2500 paired end sequencing; GSM4743491: 4_SCL; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251322,4_SCL,Homo sapiens,sclerotome,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743491: 4_SCL; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/007/SRR12507507/SRR12507507.fastq.gz', 'md5': 'a1e6199d9ba0287b48b9183dc408a11b', 'size': '21980806931'}]",iPS-derived sclerotome,,,,,,,,,
SRR12507508,SRX8998542,Illumina HiSeq 2500 paired end sequencing; GSM4743492: 5_SYN_day2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251323,5_SYN_day2,Homo sapiens,syndetome,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743492: 5_SYN_day2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/008/SRR12507508/SRR12507508.fastq.gz', 'md5': '47e3574b69e9d8b567e8e0af2ac64260', 'size': '18487761933'}]",iPS-derived syndetome,,,,,,,,,
SRR12507509,SRX8998543,Illumina HiSeq 2500 paired end sequencing; GSM4743493: 6_SYN_day4; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251324,6_SYN_day4,Homo sapiens,syndetome,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743493: 6_SYN_day4; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/009/SRR12507509/SRR12507509.fastq.gz', 'md5': '3771b0f41fb484e33a24d5ee15ddb297', 'size': '16654876929'}]",iPS-derived syndetome,,,,,,,,,
SRR12507510,SRX8998544,Illumina HiSeq 2500 paired end sequencing; GSM4743494: 7_SYN_day6; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251325,7_SYN_day6,Homo sapiens,syndetome,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743494: 7_SYN_day6; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/010/SRR12507510/SRR12507510.fastq.gz', 'md5': '6beb786490fe1f5952009087826b3f47', 'size': '16484355134'}]",iPS-derived syndetome,,,,,,,,,
SRR12507511,SRX8998545,Illumina HiSeq 2500 paired end sequencing; GSM4743495: 8_SYN_day8; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251326,8_SYN_day8,Homo sapiens,syndetome,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743495: 8_SYN_day8; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/011/SRR12507511/SRR12507511.fastq.gz', 'md5': '16b0b6a055e62ad5fe883b33baf4d0f6', 'size': '16925590015'}]",iPS-derived syndetome,,,,,,,,,
SRR17818942,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818942/SRR17818942.fastq.gz', 'md5': 'f63b70bddd78bbdb93d0eee58cf0e740', 'size': '1782388135'}]",RD cell line,Wild type,,,,,,,,
SRR17818943,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818943/SRR17818943.fastq.gz', 'md5': '6e62f25b6e3e2fadcb10b7b6bd2ed18b', 'size': '1814703290'}]",RD cell line,Wild type,,,,,,,,
SRR17818944,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818944/SRR17818944.fastq.gz', 'md5': '670f44c639e9b364b9da55a7f046c4c4', 'size': '1809812263'}]",RD cell line,Wild type,,,,,,,,
SRR17818945,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818945/SRR17818945.fastq.gz', 'md5': 'ce04ed2b32ce0ead1395a10ef8a00cdf', 'size': '1830816188'}]",RD cell line,Wild type,,,,,,,,
SRR17818954,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818954/SRR17818954.fastq.gz', 'md5': '25158b412e8833f512faa736cc8ede63', 'size': '2236224295'}]",RD cell line,Wild type,,,,,,,,
SRR17818955,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818955/SRR17818955.fastq.gz', 'md5': '4bb4b4a019e433c0d1426e0513dcca52', 'size': '2263388708'}]",RD cell line,Wild type,,,,,,,,
SRR17818956,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/056/SRR17818956/SRR17818956.fastq.gz', 'md5': '313915566949d53d2f28e65bd386257a', 'size': '2268458770'}]",RD cell line,Wild type,,,,,,,,
SRR17818957,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/057/SRR17818957/SRR17818957.fastq.gz', 'md5': 'e835070df2afd0bf019b7539a197c329', 'size': '2286830846'}]",RD cell line,Wild type,,,,,,,,
SRR17818958,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/058/SRR17818958/SRR17818958.fastq.gz', 'md5': 'c4bcb2710ab0e08190d17edbe79a28b5', 'size': '2151521366'}]",RD cell line,Wild type,,,,,,,,
SRR17818959,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17818959/SRR17818959.fastq.gz', 'md5': 'f501ce0fc93abffa5dcdbc434278de68', 'size': '2163967531'}]",RD cell line,Wild type,,,,,,,,
SRR17818960,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818960/SRR17818960.fastq.gz', 'md5': '5a3d45192e386a4366eb6be4fd79b233', 'size': '2192886584'}]",RD cell line,Wild type,,,,,,,,
SRR17818961,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818961/SRR17818961.fastq.gz', 'md5': '7419fae90b701615574016ac494483dc', 'size': '2183900191'}]",RD cell line,Wild type,,,,,,,,
SRR17818962,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818962/SRR17818962.fastq.gz', 'md5': 'a4b4d68b8719bbadd68d27e2357fba54', 'size': '2022607976'}]",RD cell line,Wild type,,,,,,,,
SRR17818963,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/063/SRR17818963/SRR17818963.fastq.gz', 'md5': '7ab2011888ff077593e66c5bc601f9d6', 'size': '2036530338'}]",RD cell line,Wild type,,,,,,,,
SRR17818964,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818964/SRR17818964.fastq.gz', 'md5': '424a1d45e56ac843206f2771e4b48222', 'size': '2061293023'}]",RD cell line,Wild type,,,,,,,,
SRR17818965,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818965/SRR17818965.fastq.gz', 'md5': '3251a7a72b0163c1d58300a7b715389f', 'size': '2055031989'}]",RD cell line,Wild type,,,,,,,,
SRR10897760,SRX7566587,NextSeq 500 paired end sequencing; GSM4272893: hu07_021219; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002992,hu07_021219,Homo sapiens,Flexor hallucis longus,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272893: hu07_021219; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/060/SRR10897760/SRR10897760_1.fastq.gz', 'md5': 'c2d6d629984a68481cbbd25e64653d2c', 'size': '4816064719'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/060/SRR10897760/SRR10897760_2.fastq.gz', 'md5': '9815a0953d9747131e79037bf2c00e09', 'size': '7848854661'}]",,,71,male,Flexor hallucis longus,205111188,17024228604,,,
SRR10897761,SRX7566588,NextSeq 500 paired end sequencing; GSM4272894: hu01_061419; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002993,hu01_061419,Homo sapiens,Right serratus,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272894: hu01_061419; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/061/SRR10897761/SRR10897761_1.fastq.gz', 'md5': '966998b4f5cb31b4d84838a2dafca4d8', 'size': '4355909688'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/061/SRR10897761/SRR10897761_2.fastq.gz', 'md5': 'dcb260c2641165d238cd9009404314ee', 'size': '7238559816'}]",,,74,male,Right serratus,186309991,15463729253,,,
SRR10897762,SRX7566589,NextSeq 500 paired end sequencing; GSM4272895: hu02_062419; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002994,hu02_062419,Homo sapiens,Flexor hallucis longus,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272895: hu02_062419; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/062/SRR10897762/SRR10897762_1.fastq.gz', 'md5': '09677babc0fa84cc9b66435220947c88', 'size': '5096253366'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/062/SRR10897762/SRR10897762_2.fastq.gz', 'md5': '7fc591068e841c76970e2e887d907bfb', 'size': '7895906465'}]",,,54,male,Flexor hallucis longus,224127206,18602558098,,,
SRR10897763,SRX7566590,NextSeq 500 paired end sequencing; GSM4272896: hu03_062719; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002995,hu03_062719,Homo sapiens,Orbicularis oris,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272896: hu03_062719; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/063/SRR10897763/SRR10897763_1.fastq.gz', 'md5': '1b15b4492874db07d3aba6986cc43aa5', 'size': '4882841084'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/063/SRR10897763/SRR10897763_2.fastq.gz', 'md5': 'ee39d71c28838b12d768c73c8bda6cf4', 'size': '7988824993'}]",,,74,male,Orbicularis oris,221645556,18396581148,,,
SRR10897764,SRX7566591,NextSeq 500 paired end sequencing; GSM4272897: hu04_080619; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002996,hu04_080619,Homo sapiens,Eye lid,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272897: hu04_080619; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/064/SRR10897764/SRR10897764_1.fastq.gz', 'md5': '301d07fef5c76080a5eedf6551a6a3dc', 'size': '4744778657'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/064/SRR10897764/SRR10897764_2.fastq.gz', 'md5': '0a11d7b98ac2518f7056111d741d5f11', 'size': '7739658658'}]",,,77,female,Eye lid,210524102,17473500466,,,
SRR10897765,SRX7566592,NextSeq 500 paired end sequencing; GSM4272898: hu08_092618; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002997,hu08_092618,Homo sapiens,Left vastus lateralis,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272898: hu08_092618; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/065/SRR10897765/SRR10897765_1.fastq.gz', 'md5': '2fa6995c5db5f0b1dd997ce06580f1c0', 'size': '5231716230'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/065/SRR10897765/SRR10897765_2.fastq.gz', 'md5': '66fc791b068d7fce5e4c7bb084aca5cb', 'size': '9454881727'}]",,,54,male,Left vastus lateralis,235694063,19798301292,,,
SRR10897766,SRX7566593,NextSeq 500 paired end sequencing; GSM4272899: hu09_092718; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002998,hu09_092718,Homo sapiens,Left external oblique,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272899: hu09_092718; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/066/SRR10897766/SRR10897766_1.fastq.gz', 'md5': '952b4edc66c219d43af5c577e6e84c8e', 'size': '5229819273'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/066/SRR10897766/SRR10897766_2.fastq.gz', 'md5': 'a429600d2c8c712c4cd74439b3215c3c', 'size': '9480789761'}]",,,70,male,Left external oblique,230378709,19351811556,,,
SRR10897767,SRX7566594,NextSeq 500 paired end sequencing; GSM4272900: hu10_101018; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002999,hu10_101018,Homo sapiens,Left rectus abdominus,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272900: hu10_101018; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/067/SRR10897767/SRR10897767_1.fastq.gz', 'md5': '080d2b8e5b0841f7bdd040733b855c88', 'size': '6038975801'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/067/SRR10897767/SRR10897767_2.fastq.gz', 'md5': 'e0df63a5c5c1d518c2b08de64a26575a', 'size': '10977572235'}]",,,43,male,Left rectus abdominus,272220748,22866542832,,,
SRR10897768,SRX7566595,NextSeq 500 paired end sequencing; GSM4272901: hu05_111418; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6003000,hu05_111418,Homo sapiens,Trapezius,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272901: hu05_111418; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/068/SRR10897768/SRR10897768_1.fastq.gz', 'md5': '5f726b59b21b2071989163a816ec34c7', 'size': '5609176862'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/068/SRR10897768/SRR10897768_2.fastq.gz', 'md5': '0b2cda6dade3c922fadbd1948d03c972', 'size': '8555300910'}]",,,62,female,Trapezius,242900230,20160719090,,,
SRR10897769,SRX7566596,NextSeq 500 paired end sequencing; GSM4272902: hu06_120518; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6003001,hu06_120518,Homo sapiens,Right external oblique,,2020-06-03,2020-06-04,NextSeq 500 paired end sequencing; GSM4272902: hu06_120518; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/069/SRR10897769/SRR10897769_1.fastq.gz', 'md5': '3aa3e79d207a5315a960a915ef15cf1a', 'size': '5507397277'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/069/SRR10897769/SRR10897769_2.fastq.gz', 'md5': 'd0e468e31e3790e31a4f9b9691216909', 'size': '8679883298'}]",,,81,female,Right external oblique,237257755,19692393665,,,
SRR16774171,SRX12973435,DNBSEQ-G400 paired end sequencing; GSM5672476: 2D expanded cells; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914287,2D expanded cells,Homo sapiens,2D expanded CD56+ myogenic cells,,2021-11-12,2021-11-12,DNBSEQ-G400 paired end sequencing; GSM5672476: 2D expanded cells; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/071/SRR16774171/SRR16774171_1.fastq.gz', 'md5': 'ab658166a7f946ac03bf90c4415dafa7', 'size': '20240679790'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/071/SRR16774171/SRR16774171_2.fastq.gz', 'md5': '43eddfa343c7a8b532ec33217efeeb36', 'size': '42647741299'}]",Primary CD56+ human myoblasts expanded for 5 passages with p38 inhibitor (SB203580),,,,,,,,,
SRR16774172,SRX12973436,DNBSEQ-G400 paired end sequencing; GSM5672477: 3-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914288,3-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,2021-11-12,2021-11-12,DNBSEQ-G400 paired end sequencing; GSM5672477: 3-day differentiated myobundles; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/072/SRR16774172/SRR16774172_1.fastq.gz', 'md5': '04d87086579568df82220f8e78fe1af4', 'size': '12819609108'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/072/SRR16774172/SRR16774172_2.fastq.gz', 'md5': '4336b96619d17121fca65ca8c92b344b', 'size': '20539958695'}]",Cells dissociated from myobundles (4 days growth media followed by 3 days differentiation media),,,,,,,,,
SRR16774173,SRX12973437,DNBSEQ-G400 paired end sequencing; GSM5672478: 9-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914289,9-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,2021-11-12,2021-11-12,DNBSEQ-G400 paired end sequencing; GSM5672478: 9-day differentiated myobundles; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/073/SRR16774173/SRR16774173_1.fastq.gz', 'md5': '37869ee19ffee5c687fb7571f7527d66', 'size': '13378566042'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/073/SRR16774173/SRR16774173_2.fastq.gz', 'md5': 'e0d5c005fade9d9c8591b08684489252', 'size': '26468480837'}]",Cells dissociated from myobundles (4 days growth media followed by 9 days differentiation media),,,,,,,,,
SRR16774174,SRX12973438,DNBSEQ-G400 paired end sequencing; GSM5672479: 2 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914290,2 days post injury of 7-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,2021-11-12,2021-11-12,DNBSEQ-G400 paired end sequencing; GSM5672479: 2 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/074/SRR16774174/SRR16774174_1.fastq.gz', 'md5': '89b96fd807aed86645dc2d11af8196ce', 'size': '11905358660'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/074/SRR16774174/SRR16774174_2.fastq.gz', 'md5': 'd97de4247309b78f3a60e2b78b4c72cd', 'size': '16613301777'}]","Cells dissociated from myobundles (4 days growth media, melittin-injured on day 7 of differentiation, samples isolated at 2 days post-injury). This sample is age-matched with d9.",,,,,,,,,
SRR16774175,SRX12973439,DNBSEQ-G400 paired end sequencing; GSM5672480: 5 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914291,5 days post injury of 7-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,2021-11-12,2021-11-12,DNBSEQ-G400 paired end sequencing; GSM5672480: 5 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/075/SRR16774175/SRR16774175_1.fastq.gz', 'md5': '8cbc6f3d681534e7c98a9e1253d3958a', 'size': '7127626025'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/075/SRR16774175/SRR16774175_2.fastq.gz', 'md5': '5bd5c5f3b9eaa1c31238e473c10ee0ec', 'size': '8760663748'}]","Cells dissociated from myobundles (4 days growth media, melittin-injured on day 7 of differentiation, samples isolated at 5 days post-injury)",,,,,,,,,
SRR10914868,SRX7582270,Illumina HiSeq 4000 paired end sequencing; GSM4276650: Day 50 NM organoid 4; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP188565,Self-organizing human trunk 3D neuromuscular organoids,"Neuromuscular networks assemble during early human embryonic development and are essential for the control of body movement. Previous neuromuscular junction modeling efforts using human pluripotent stem cells (hPSCs) generated either spinal cord neurons or skeletal muscles in monolayer culture. Here, we use hPSC-derived axial stem cells, the building blocks of the posterior body, to simultaneously generate spinal cord neurons and skeletal muscle cells that self-organize to generate human neuromuscular organoids (NMOs) that can be maintained in 3D for several months. Single-cell RNA-sequencing of individual organoids revealed reproducibility across experiments and enabled the tracking of the neural and mesodermal differentiation trajectories as organoids developed and matured. NMOs contain functional neuromuscular junctions supported by terminal Schwann cells. They contract and develop central pattern generator-like neuronal circuits. Finally, we successfully use NMOs to recapitulate key aspects of myasthenia gravis pathology, thus highlighting the significant potential of NMOs for modeling neuromuscular diseases in the future. Overall design: We have analyzed single cells from 10 organoids at Day 5. The organoids were separated in two samples (5 pooled organoids each) and labelled with different indexes. In total 5,135 cells were analyzed with a median of 3,333 genes per cell. For Day 50 we analyzed 4 organoids. One sample consisted of one organoid analyzed independently, and the other Day 50 sample consisted of 3 organoids tagged with different indexes. In total 17,294 cells were analyzed with a median of 2,343 genes per cell.",SRS6015922,Day 50 NM organoid 4,Homo sapiens,Neuromuscular organoid,,2020-01-21,2020-01-21,Illumina HiSeq 4000 paired end sequencing; GSM4276650: Day 50 NM organoid 4; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/068/SRR10914868/SRR10914868.fastq.gz', 'md5': '70fcf8925eca39417c7e6617d582ad82', 'size': '25044093640'}]",,,,,Neuromuscular organoid. Time point: 50 days differentiated.,331850027,32521302646,,,
SRR14854694,SRX11173098,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231407,SJRHB030680_X1_organoid,Homo sapiens,Organoid,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/094/SRR14854694/SRR14854694.fastq.gz', 'md5': 'decd00aa597d0e8be6bdaee5e93ca7f6', 'size': '8007221908'}]",,,,,organoid,,,10x genomics 3' scRNA-seq,,
SRR14854693,SRX11173098,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231407,SJRHB030680_X1_organoid,Homo sapiens,Organoid,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/093/SRR14854693/SRR14854693.fastq.gz', 'md5': '03cead505d8dba663428d3aea484c1ce', 'size': '7928134583'}]",,,,,organoid,,,10x genomics 3' scRNA-seq,,
SRR10239195,SRX6958376,Illumina HiSeq 2500 paired end sequencing; GSM4110112: BL6_Ach_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485200,BL6_Ach_1,Mus musculus,Achilles tendon,,2019-10-12,2019-10-12,Illumina HiSeq 2500 paired end sequencing; GSM4110112: BL6_Ach_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/095/SRR10239195/SRR10239195.fastq.gz', 'md5': 'eb9252e92cd0b678e7e4da87b53c0744', 'size': '18553408059'}]",,C57Bl/6,6 weeks,male,,247012608,24207235584,,,
SRR10239196,SRX6958377,Illumina HiSeq 2500 paired end sequencing; GSM4110113: BL6_Ach_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485201,BL6_Ach_2,Mus musculus,Achilles tendon,,2019-10-12,2019-10-12,Illumina HiSeq 2500 paired end sequencing; GSM4110113: BL6_Ach_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/096/SRR10239196/SRR10239196.fastq.gz', 'md5': 'ad052b2c808c1e6d62f3e0355d279c26', 'size': '18549976302'}]",,C57Bl/6,6 weeks,male,,258373416,25320594768,,,
SRR10239197,SRX6958378,Illumina HiSeq 2500 paired end sequencing; GSM4110114: BL6_Ach_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485202,BL6_Ach_3,Mus musculus,Achilles tendon,,2019-10-12,2019-10-12,Illumina HiSeq 2500 paired end sequencing; GSM4110114: BL6_Ach_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/097/SRR10239197/SRR10239197.fastq.gz', 'md5': 'a7fbbd140d0b12b101ad91f1fae06ebe', 'size': '18408018951'}]",,C57Bl/6,6 weeks,male,,251649141,24661615818,,,
SRR10239198,SRX6958375,Illumina HiSeq 2500 paired end sequencing; GSM4110115: BL6_Ach_4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485199,BL6_Ach_4,Mus musculus,Achilles tendon,,2019-10-12,2019-10-12,Illumina HiSeq 2500 paired end sequencing; GSM4110115: BL6_Ach_4; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/098/SRR10239198/SRR10239198.fastq.gz', 'md5': '73f140714781ac3becd61e45433d54b6', 'size': '18731194141'}]",,C57Bl/6,6 weeks,male,,244113182,23923091836,,,
SRR12507512,SRX8998546,Illumina HiSeq 2500 paired end sequencing; GSM4743496: 9_primary_tenocyte; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251327,9_primary_tenocyte,Homo sapiens,tenocyte,,2021-07-21,2021-07-21,Illumina HiSeq 2500 paired end sequencing; GSM4743496: 9_primary_tenocyte; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/012/SRR12507512/SRR12507512.fastq.gz', 'md5': 'a2269cf195d9b6cac1aa6495987ccb6c', 'size': '18616617775'}]",primary tenocyte,,,,,,,,,
SRR14854525,SRX11173038,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231348,SJRHB031320_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/025/SRR14854525/SRR14854525.fastq.gz', 'md5': 'f7956086e77f262ca9d710e848dd383e', 'size': '6972329845'}]",,,,,tumor,,,10x genomics 3' scRNA-seq,,
SRR14854526,SRX11173038,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231348,SJRHB031320_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/026/SRR14854526/SRR14854526.fastq.gz', 'md5': 'e83d4f8b1c092ef082e9c58d89cab34f', 'size': '7008326129'}]",,,,,tumor,,,10x genomics 3' scRNA-seq,,
SRR14854527,SRX11173039,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231349,SJRHB000026_R2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/027/SRR14854527/SRR14854527.fastq.gz', 'md5': 'ce2515cfefb5fa7f1ac522cd74d41236', 'size': '5791547987'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854528,SRX11173039,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231349,SJRHB000026_R2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/028/SRR14854528/SRR14854528.fastq.gz', 'md5': 'cb087cacdd5ef88d77168c7ba97e89fa', 'size': '5839487244'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854529,SRX11173040,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231350,SJRHB000026_R3,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/029/SRR14854529/SRR14854529.fastq.gz', 'md5': '217e46144bfc439529b20f44c07a9132', 'size': '6927416208'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854530,SRX11173040,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231350,SJRHB000026_R3,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/030/SRR14854530/SRR14854530.fastq.gz', 'md5': '2f56c16a65586d5634f94a797c3c6e2c', 'size': '7033364638'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854531,SRX11173041,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231351,SJRHB010927_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/031/SRR14854531/SRR14854531.fastq.gz', 'md5': '59423aa074f2018cf86e4c807b9278df', 'size': '6751032817'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854532,SRX11173041,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231351,SJRHB010927_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/032/SRR14854532/SRR14854532.fastq.gz', 'md5': 'cd14f5a34ea70c36905a922d8ca38f43', 'size': '6793068630'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854533,SRX11173042,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231352,SJRHB010928_R1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/033/SRR14854533/SRR14854533.fastq.gz', 'md5': 'b4cd822d25a8c2d9910f978071b60a41', 'size': '10844115344'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854534,SRX11173042,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231352,SJRHB010928_R1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/034/SRR14854534/SRR14854534.fastq.gz', 'md5': 'fbd5f5f73db917eedb85c8a322d09668', 'size': '11295078279'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854535,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/035/SRR14854535/SRR14854535.fastq.gz', 'md5': 'd1214940ad1c6fd0c34e81ac9ad2355d', 'size': '3495259302'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854536,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/036/SRR14854536/SRR14854536.fastq.gz', 'md5': '0f7c1307155d8f08c9a9f4e093d46b34', 'size': '3477136510'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854537,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/037/SRR14854537/SRR14854537.fastq.gz', 'md5': 'b22c927ad4d124288f3b0cb580ac4d8a', 'size': '3548920714'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854538,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/038/SRR14854538/SRR14854538.fastq.gz', 'md5': '3c4e68d23f7e6133eae725477ad220d5', 'size': '3574375609'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854539,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/039/SRR14854539/SRR14854539.fastq.gz', 'md5': '522fd560a52355167c6dd94cdf84bf8c', 'size': '4161853170'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854540,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/040/SRR14854540/SRR14854540.fastq.gz', 'md5': '99da4106fe778ca4bef2e0a8b6c5798c', 'size': '4144599954'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854541,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/041/SRR14854541/SRR14854541.fastq.gz', 'md5': '60b0a495e3bf2b6a1cee34da9905ab8a', 'size': '4215414194'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854542,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/042/SRR14854542/SRR14854542.fastq.gz', 'md5': '003bc0d16d841c0b285e80c915334200', 'size': '4249511290'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854543,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/043/SRR14854543/SRR14854543.fastq.gz', 'md5': 'c5adb869714fec32b24e16290703268d', 'size': '4744987426'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854544,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/044/SRR14854544/SRR14854544.fastq.gz', 'md5': 'cf85b6779ec9c58ac453a10c0a8bff55', 'size': '4629948528'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854552,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/052/SRR14854552/SRR14854552.fastq.gz', 'md5': 'd48dbdae6b8578cb47d5876893c1f4d7', 'size': '4848941194'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854553,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/053/SRR14854553/SRR14854553.fastq.gz', 'md5': '44596b47ae068a987cdc65c164c2457b', 'size': '4960995626'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854554,SRX11173047,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231357,SJRHB012405_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/054/SRR14854554/SRR14854554.fastq.gz', 'md5': '7c5136f4cbf0792dae9f2441b942c1c7', 'size': '6331149775'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854555,SRX11173047,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231357,SJRHB012405_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/055/SRR14854555/SRR14854555.fastq.gz', 'md5': '6085aae78f9aca2e4651f086d20fda16', 'size': '6366561421'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854556,SRX11173048,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231358,SJRHB013758_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/056/SRR14854556/SRR14854556.fastq.gz', 'md5': 'fd1ab564d003f93621cd63bf1342fcb1', 'size': '7062966570'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854557,SRX11173048,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231358,SJRHB013758_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/057/SRR14854557/SRR14854557.fastq.gz', 'md5': 'b9dcab66cc6d5e5832bdf5f1436d1cb2', 'size': '7125674107'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854558,SRX11173049,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231359,SJRHB013758_D2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/058/SRR14854558/SRR14854558.fastq.gz', 'md5': '09ab9431a01689de33f98cee4fb8646e', 'size': '6021333474'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854559,SRX11173049,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231359,SJRHB013758_D2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/059/SRR14854559/SRR14854559.fastq.gz', 'md5': '2c0a453938179a82ea94aaf5313d446c', 'size': '6066473796'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854560,SRX11173050,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231360,SJRHB049189_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/060/SRR14854560/SRR14854560.fastq.gz', 'md5': '07a7e6982908d46806e3585b8be54d18', 'size': '5383576544'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854561,SRX11173050,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231360,SJRHB049189_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/061/SRR14854561/SRR14854561.fastq.gz', 'md5': 'ceb8a1289d62f00882850404c01f0f18', 'size': '5419379662'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854562,SRX11173051,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231361,SJRHB030680_R1_sn,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/062/SRR14854562/SRR14854562.fastq.gz', 'md5': '98bd5a27e84dae62f5b8ea5e319dc3c1', 'size': '5147172877'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854563,SRX11173051,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231361,SJRHB030680_R1_sn,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/063/SRR14854563/SRR14854563.fastq.gz', 'md5': '2bdb53e0bf72545cad81efcf3c03ebf8', 'size': '5140091051'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854564,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/064/SRR14854564/SRR14854564.fastq.gz', 'md5': 'bb34f5f7441a719622f4cf41774a8618', 'size': '3786641378'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854565,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/065/SRR14854565/SRR14854565.fastq.gz', 'md5': 'd6e4261019ac0d942db7f999b2327a18', 'size': '3715214753'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854566,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/066/SRR14854566/SRR14854566.fastq.gz', 'md5': 'c141894372a4d965e9aa5ff13d46257d', 'size': '3848335137'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854567,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/067/SRR14854567/SRR14854567.fastq.gz', 'md5': '70f70b456f3041ef72182ba0b8991843', 'size': '3930973631'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854568,SRX11173053,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231363,SJRHB013757_D2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/068/SRR14854568/SRR14854568.fastq.gz', 'md5': '9af57b00e09353d2dd4ece315616609f', 'size': '6099713873'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854569,SRX11173053,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231363,SJRHB013757_D2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/069/SRR14854569/SRR14854569.fastq.gz', 'md5': '4b14e4b27e16fcdea445538526ed3e31', 'size': '6118810908'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854570,SRX11173054,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231364,SJRHB013759_A1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/070/SRR14854570/SRR14854570.fastq.gz', 'md5': '396fa704c6f4a0e8163b736e8ef4afcd', 'size': '6481085361'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854571,SRX11173054,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231364,SJRHB013759_A1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/071/SRR14854571/SRR14854571.fastq.gz', 'md5': 'b216962257ff5d92bd8f9254450763aa', 'size': '6515394578'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854572,SRX11173055,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231365,SJRHB013759_A2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/072/SRR14854572/SRR14854572.fastq.gz', 'md5': 'b0b8c8347575c442a40ef9b3c5cffaf5', 'size': '6743016493'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854573,SRX11173055,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231365,SJRHB013759_A2,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/073/SRR14854573/SRR14854573.fastq.gz', 'md5': '7f5b42adfe462b0ee0973968bf12fd66', 'size': '6807456202'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854574,SRX11173056,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231366,SJRHB046156_A1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/074/SRR14854574/SRR14854574.fastq.gz', 'md5': '757426c76606540cf15774a5962e6a0d', 'size': '5516595277'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854575,SRX11173056,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231366,SJRHB046156_A1,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/075/SRR14854575/SRR14854575.fastq.gz', 'md5': '6929783abd2af661bed71fd9a2012dee', 'size': '5545170980'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854576,SRX11173057,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231367,SJRHB031320_D1_sn,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/076/SRR14854576/SRR14854576.fastq.gz', 'md5': 'f5ca820f5189279a6f8e3612648587ec', 'size': '4806693621'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR14854577,SRX11173057,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231367,SJRHB031320_D1_sn,Homo sapiens,Patient tumor,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/077/SRR14854577/SRR14854577.fastq.gz', 'md5': '4018c7587c1b706aba8b78bcd7ed7b83', 'size': '4826771575'}]",,,,,tumor,,,10x genomics 3' snRNA-seq,,
SRR17818970,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818970/SRR17818970.fastq.gz', 'md5': '04dde173126b8dba2adfb3c286b4dd20', 'size': '5896718773'}]",Primary cell,Wild type,,,,,,,,
SRR17818971,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818971/SRR17818971.fastq.gz', 'md5': 'db7f0895b6a05be9f7c240a519ef01e8', 'size': '5951983457'}]",Primary cell,Wild type,,,,,,,,
SRR17818972,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818972/SRR17818972.fastq.gz', 'md5': '6f4287f21bac2d958c5659c811317abe', 'size': '5828359971'}]",Primary cell,Wild type,,,,,,,,
SRR17818973,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818973/SRR17818973.fastq.gz', 'md5': '20e942b62ec10f471cea18d09a393a94', 'size': '5963397085'}]",Primary cell,Wild type,,,,,,,,
SRR17818974,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818974/SRR17818974.fastq.gz', 'md5': 'ad4cc0ed9da97545574cd2ad1154bf5e', 'size': '6102431836'}]",Primary cell,Wild type,,,,,,,,
SRR17818975,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818975/SRR17818975.fastq.gz', 'md5': '7288d480dad9304ccbcb0f1251d89a1e', 'size': '6141553107'}]",Primary cell,Wild type,,,,,,,,
SRR17818976,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818976/SRR17818976.fastq.gz', 'md5': 'f636a4aeaee0479194d41235c9e749e8', 'size': '6145205179'}]",Primary cell,Wild type,,,,,,,,
SRR17818977,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818977/SRR17818977.fastq.gz', 'md5': '71e39fe049afabf2256298b1b43f6067', 'size': '6213816161'}]",Primary cell,Wild type,,,,,,,,
SRR17818978,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818978/SRR17818978.fastq.gz', 'md5': '57220c6fa70772b72d6ea73079b2b43f', 'size': '4290451241'}]",Primary cell,Wild type,,,,,,,,
SRR17818979,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818979/SRR17818979.fastq.gz', 'md5': '2f492bbc11a4d493cacd821b474bb212', 'size': '4429060772'}]",Primary cell,Wild type,,,,,,,,
SRR17818980,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818980/SRR17818980.fastq.gz', 'md5': '7a2b119bdd6fe1e4fdfcd13a5239bf6e', 'size': '4353100303'}]",Primary cell,Wild type,,,,,,,,
SRR17818981,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818981/SRR17818981.fastq.gz', 'md5': 'a059754978c71fcfdcbb5af291eeb68a', 'size': '4505802337'}]",Primary cell,Wild type,,,,,,,,
SRR17818982,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818982/SRR17818982.fastq.gz', 'md5': 'b9d5aef87716795276098ec2bc52f5d3', 'size': '5438883368'}]",Primary cell,Wild type,,,,,,,,
SRR17818983,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818983/SRR17818983.fastq.gz', 'md5': '930627d74d0b1f7eb8944a6478629785', 'size': '5559279295'}]",Primary cell,Wild type,,,,,,,,
SRR17818984,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818984/SRR17818984.fastq.gz', 'md5': 'fb9887fca5fafb3eff4f7036bf6645fe', 'size': '5455332526'}]",Primary cell,Wild type,,,,,,,,
SRR17818985,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818985/SRR17818985.fastq.gz', 'md5': 'd98983e45d3f44e8962be00c78e12ecd', 'size': '5572475120'}]",Primary cell,Wild type,,,,,,,,
SRR14854578,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/078/SRR14854578/SRR14854578.fastq.gz', 'md5': 'd2499bc066c06b954144300b0a24a7cc', 'size': '2253904103'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854579,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/079/SRR14854579/SRR14854579.fastq.gz', 'md5': '5d85df3dc702a7fe57cf8000a780e36c', 'size': '767084943'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854580,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/080/SRR14854580/SRR14854580.fastq.gz', 'md5': 'b740054d5a542c701eaa8197661ba109', 'size': '401789770'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854581,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/081/SRR14854581/SRR14854581.fastq.gz', 'md5': '7a7a2d21bbc8fe5c98f25aa3dd1832b9', 'size': '512874737'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854582,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/082/SRR14854582/SRR14854582.fastq.gz', 'md5': 'b17616f9b6688b8dc24ddbd26e3da750', 'size': '225593811'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854583,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/083/SRR14854583/SRR14854583.fastq.gz', 'md5': 'd7b3c27a0f68389095dd95e6e48ae658', 'size': '289117528'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854584,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/084/SRR14854584/SRR14854584.fastq.gz', 'md5': '7bb58b6333adada3c005316da87bbc8d', 'size': '492875518'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854585,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/085/SRR14854585/SRR14854585.fastq.gz', 'md5': '8acf3f1e815c9a917413c1e869428a98', 'size': '630583233'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854586,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/086/SRR14854586/SRR14854586.fastq.gz', 'md5': 'b88ccc3d6c4ac30bba9e3e83bd11be17', 'size': '2313845630'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854587,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/087/SRR14854587/SRR14854587.fastq.gz', 'md5': '6deaf158e8802d7e40a4dfb962b50cd1', 'size': '1550164974'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854588,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/088/SRR14854588/SRR14854588.fastq.gz', 'md5': '0edddc0deb1b2b89e2ec65ebbbda7520', 'size': '1581922401'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854589,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/089/SRR14854589/SRR14854589.fastq.gz', 'md5': '3cd673ba8b21a11f01d1a2b0881fcbb0', 'size': '886485776'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854590,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/090/SRR14854590/SRR14854590.fastq.gz', 'md5': '7becce648d98344680548c4d2ba77cb7', 'size': '911872411'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854591,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/091/SRR14854591/SRR14854591.fastq.gz', 'md5': 'bc9f5581c99e0d6bfd91a65a4504393f', 'size': '1893240523'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854592,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/092/SRR14854592/SRR14854592.fastq.gz', 'md5': '387dead99b6dd6dede669d754c53145a', 'size': '1952280103'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854593,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/093/SRR14854593/SRR14854593.fastq.gz', 'md5': 'eb8261f3f9a9ae91c6e5b10c6a70888f', 'size': '601427512'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854594,SRX11173059,Illumina NovaSeq 6000 paired end sequencing; GSM5390476: SJRHB000026_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231368,SJRHB000026_X2,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390476: SJRHB000026_X2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/094/SRR14854594/SRR14854594.fastq.gz', 'md5': '5b10d267a8116ecff692aa15e9047d12', 'size': '26061600128'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854595,SRX11173060,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231370,SJRHB010927_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/095/SRR14854595/SRR14854595.fastq.gz', 'md5': '082b43c27c4e5c8a95383395dbdd9a9d', 'size': '5721538234'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854596,SRX11173060,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231370,SJRHB010927_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/096/SRR14854596/SRR14854596.fastq.gz', 'md5': '45758381e93474570f4425336c340ec5', 'size': '5746902808'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854597,SRX11173061,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231371,SJRHB010928_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/097/SRR14854597/SRR14854597.fastq.gz', 'md5': '7106baef8a3680dbd6dc4d49585906ba', 'size': '8087970031'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854598,SRX11173061,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231371,SJRHB010928_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/098/SRR14854598/SRR14854598.fastq.gz', 'md5': '244f7061c1c78d0ef5a3fcfa59595a02', 'size': '8114553408'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854599,SRX11173062,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231372,SJRHB011_X,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/099/SRR14854599/SRR14854599.fastq.gz', 'md5': '70873b12b8cf7ee006b9e755d99d8d0d', 'size': '7041267272'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854600,SRX11173062,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231372,SJRHB011_X,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/000/SRR14854600/SRR14854600.fastq.gz', 'md5': '092909a6bf1315bc2fabcb317bd8d9e5', 'size': '7018592380'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854601,SRX11173063,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231374,SJRHB012_Y,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/001/SRR14854601/SRR14854601.fastq.gz', 'md5': '4a23f157492068515767496af3e09dce', 'size': '6454199786'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854602,SRX11173063,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231374,SJRHB012_Y,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/002/SRR14854602/SRR14854602.fastq.gz', 'md5': 'bd74dc94b449bbb131d4dc076ef08c2d', 'size': '6427046787'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854603,SRX11173064,Illumina NovaSeq 6000 paired end sequencing; GSM5390481: SJRHB012_Z; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231373,SJRHB012_Z,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390481: SJRHB012_Z; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/003/SRR14854603/SRR14854603.fastq.gz', 'md5': 'd57dc4163ae227bf87cc937137391e1e', 'size': '17425444479'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854604,SRX11173065,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231375,SJRHB012405_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/004/SRR14854604/SRR14854604.fastq.gz', 'md5': '836fdb6aba5be6a9edc421d214988f93', 'size': '8466509413'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854605,SRX11173065,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231375,SJRHB012405_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/005/SRR14854605/SRR14854605.fastq.gz', 'md5': '0936b1f5a266a5268c7da538b432e5b8', 'size': '8615953867'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854606,SRX11173066,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231376,SJRHB013758_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/006/SRR14854606/SRR14854606.fastq.gz', 'md5': '3276929e937396175d4520d07677de22', 'size': '6018638316'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854607,SRX11173066,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231376,SJRHB013758_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/007/SRR14854607/SRR14854607.fastq.gz', 'md5': '28277192b534e4d44d7b78d8cdcc8a50', 'size': '5995218797'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854608,SRX11173067,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231377,SJRHB013758_X2,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/008/SRR14854608/SRR14854608.fastq.gz', 'md5': 'c3ecc77423e2d5d1b5823a06db7b9fd7', 'size': '4202863281'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854609,SRX11173067,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231377,SJRHB013758_X2,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/009/SRR14854609/SRR14854609.fastq.gz', 'md5': '6c4eaa0784b867ec89d4ac0bb7cc2cc3', 'size': '4236164637'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854610,SRX11173068,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231378,SJRHB049189_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/010/SRR14854610/SRR14854610.fastq.gz', 'md5': 'fcf706bfbd43c42aa437e557043e869b', 'size': '5010540054'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854611,SRX11173068,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231378,SJRHB049189_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/011/SRR14854611/SRR14854611.fastq.gz', 'md5': 'c92542924a190e417cade53b24733bee', 'size': '5031426986'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854612,SRX11173069,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231380,SJRHB030680_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/012/SRR14854612/SRR14854612.fastq.gz', 'md5': '05496c5648528407718b7a39c7442313', 'size': '4260149316'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854613,SRX11173069,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231380,SJRHB030680_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/013/SRR14854613/SRR14854613.fastq.gz', 'md5': '96f1fde08e6190b42ba821422e4e0d0a', 'size': '4250962223'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854614,SRX11173070,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231379,SJRHB010468_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/014/SRR14854614/SRR14854614.fastq.gz', 'md5': 'a772041f3296735cc839d6e0d54aab06', 'size': '6064553547'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854615,SRX11173070,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231379,SJRHB010468_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/015/SRR14854615/SRR14854615.fastq.gz', 'md5': '54028a5f854c1d8a99823107ac4f438c', 'size': '6095531689'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854616,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/016/SRR14854616/SRR14854616.fastq.gz', 'md5': 'de8a04f72f2c1eb992d9f0ab199bde2a', 'size': '4095551335'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854617,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/017/SRR14854617/SRR14854617.fastq.gz', 'md5': '183f9cdfabea9ae719af2acf2dff416f', 'size': '4091625501'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854618,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/018/SRR14854618/SRR14854618.fastq.gz', 'md5': '0409213ebbbde6c48fd0f367b5feb9b6', 'size': '4146324681'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854619,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/019/SRR14854619/SRR14854619.fastq.gz', 'md5': 'c1978297b640fea113a491458e5365f7', 'size': '4164099186'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854620,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/020/SRR14854620/SRR14854620.fastq.gz', 'md5': 'a61c8ff7b1986271970747cc4207f8f9', 'size': '1538731731'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854621,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/021/SRR14854621/SRR14854621.fastq.gz', 'md5': '3f3baee3b7210b1b422db3f3e3d0bb43', 'size': '1618963544'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854622,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/022/SRR14854622/SRR14854622.fastq.gz', 'md5': '2d8847c145bc90141f1c94eb339c1863', 'size': '1587401053'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854623,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/023/SRR14854623/SRR14854623.fastq.gz', 'md5': '68defde8b2eee2ace173f84130dc58f7', 'size': '1667652732'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854624,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/024/SRR14854624/SRR14854624.fastq.gz', 'md5': '7c958c38a9202dd77dce9d2f658d2e30', 'size': '1934336231'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854625,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/025/SRR14854625/SRR14854625.fastq.gz', 'md5': '741d07424a8bc0627558521cbe05e6a1', 'size': '2034638561'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854626,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/026/SRR14854626/SRR14854626.fastq.gz', 'md5': '59b464ce477e8227b27392bc1cee67ad', 'size': '1010644582'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854627,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/027/SRR14854627/SRR14854627.fastq.gz', 'md5': '92144304cef707d6eb1488aade74eac5', 'size': '1062943937'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854628,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/028/SRR14854628/SRR14854628.fastq.gz', 'md5': '23d0d9f2f7b3db4752023505575583a0', 'size': '3228241532'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854629,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/029/SRR14854629/SRR14854629.fastq.gz', 'md5': '7e7c9f395e6f5630ec951beabd76b90a', 'size': '3389766231'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854630,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/030/SRR14854630/SRR14854630.fastq.gz', 'md5': '1cde060f6870bffb0fad3ebfeabe6ded', 'size': '3084663298'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854631,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/031/SRR14854631/SRR14854631.fastq.gz', 'md5': '9ce4aa47f2dbc201825547604cfebadb', 'size': '3234771651'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854632,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/032/SRR14854632/SRR14854632.fastq.gz', 'md5': 'd4194b12d833e7c67cc61240689c2ad1', 'size': '4058767092'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854633,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/033/SRR14854633/SRR14854633.fastq.gz', 'md5': 'd8502a6ce669ac7daceb4a09703f2672', 'size': '4271604412'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854634,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/034/SRR14854634/SRR14854634.fastq.gz', 'md5': 'cc6a0d977a9fe0b79d37b3ada647614a', 'size': '2240234664'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854635,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/035/SRR14854635/SRR14854635.fastq.gz', 'md5': 'b8f9cc930c41e9c0c8520a9bbd25eb10', 'size': '2351543458'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854636,SRX11173074,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231384,SJRHB046156_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/036/SRR14854636/SRR14854636.fastq.gz', 'md5': '1da031a92aa8a45b2d3917ae46da1c1b', 'size': '5321682386'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854637,SRX11173074,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231384,SJRHB046156_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/037/SRR14854637/SRR14854637.fastq.gz', 'md5': '4230a55fde341c40950ff610c3ddf897', 'size': '5341527179'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854638,SRX11173075,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231385,SJRHB031320_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/038/SRR14854638/SRR14854638.fastq.gz', 'md5': 'd7b12bf53e78971f00a5c641a44caa61', 'size': '4687979042'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854639,SRX11173075,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231385,SJRHB031320_X1,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/039/SRR14854639/SRR14854639.fastq.gz', 'md5': 'a74c867c774e2315b36da5ca6c996dfc', 'size': '4672234940'}]",,,,,xenograft,,,10x genomics 3' scRNA-seq,,
SRR14854695,SRX11173099,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231409,SJRHB00026_X1_treat_day0,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/095/SRR14854695/SRR14854695.fastq.gz', 'md5': '0533d64e8ef534f31e0f4a63fc502e55', 'size': '5580010209'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR14854696,SRX11173099,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231409,SJRHB00026_X1_treat_day0,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/096/SRR14854696/SRR14854696.fastq.gz', 'md5': 'cbf9958575d24b9574467c416a7dd74e', 'size': '5551901849'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR14854697,SRX11173100,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231410,SJRHB00026_X1_treat_day3,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/097/SRR14854697/SRR14854697.fastq.gz', 'md5': '3abb3a0ba85d9a1fb9948a5f87da4a7e', 'size': '4367827841'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR14854698,SRX11173100,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231410,SJRHB00026_X1_treat_day3,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/098/SRR14854698/SRR14854698.fastq.gz', 'md5': 'e873ed0a70b854b43490ed0b775f5188', 'size': '4367495379'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR14854699,SRX11173101,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231411,SJRHB00026_X1_treat_day28,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/099/SRR14854699/SRR14854699.fastq.gz', 'md5': '2c0909a688db0af1213e211e6e7ab178', 'size': '5255981342'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR14854700,SRX11173101,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231411,SJRHB00026_X1_treat_day28,Homo sapiens,Orthotopic patient-derived xenograft,,2022-04-08,2022-04-08,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/000/SRR14854700/SRR14854700.fastq.gz', 'md5': '73acb6ed74ba981c260c4e86f6f3464a', 'size': '5238649453'}]",,,,,xenograft,,,10x genomics 3' snRNA-seq,,
SRR17818836,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818836/SRR17818836.fastq.gz', 'md5': '901bcc317599522e020ef1f7daaacf5f', 'size': '4857876270'}]",mouse PDX sample,Mutation?,,,,274599868,15102992740,,,
SRR17818837,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818837/SRR17818837.fastq.gz', 'md5': 'e930d5963bce086f5bf4c3b047141630', 'size': '4925031043'}]",mouse PDX sample,Mutation?,,,,274599868,15102992740,,,
SRR17818838,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/038/SRR17818838/SRR17818838.fastq.gz', 'md5': '51650744688bc49f62917ac77b666c7f', 'size': '4941094757'}]",mouse PDX sample,Mutation?,,,,274599868,15102992740,,,
SRR17818839,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/039/SRR17818839/SRR17818839.fastq.gz', 'md5': '48aea2e9adefcddca51f0e1368012293', 'size': '5082307001'}]",mouse PDX sample,Mutation?,,,,274599868,15102992740,,,
SRR17818840,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818840/SRR17818840_1.fastq.gz', 'md5': '60c61fe45fa505bc710015927dff6cc4', 'size': '1164142968'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818840/SRR17818840_2.fastq.gz', 'md5': '4298b456c46711104cfa67744de5f37d', 'size': '1467778221'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818841,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818841/SRR17818841_1.fastq.gz', 'md5': '512cb35c8325d7316cb4fc577da3447e', 'size': '1170063413'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818841/SRR17818841_2.fastq.gz', 'md5': '73fc3403196ad07c814b6ad9c5faf5ff', 'size': '1499182149'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818842,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818842/SRR17818842_1.fastq.gz', 'md5': '99d0974d5e499dbe2c36add6e6785f96', 'size': '1054251293'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818842/SRR17818842_2.fastq.gz', 'md5': 'b19147cbc153c03e76e0c3ad3449d13c', 'size': '1652209286'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818843,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818843/SRR17818843_1.fastq.gz', 'md5': '1f22f1ce9d5a777f3e5e4c5a64a383d0', 'size': '254652982'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818843/SRR17818843_2.fastq.gz', 'md5': '18460fe487e490963b37f18e23be8af4', 'size': '431081865'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818844,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818844/SRR17818844_1.fastq.gz', 'md5': 'f3c36eefd1e4bbda5dc338efed0120b7', 'size': '1170397951'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818844/SRR17818844_2.fastq.gz', 'md5': '6ebc31e4bc9ed9427ff1c51e662ff9a3', 'size': '1501598299'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818845,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818845/SRR17818845_1.fastq.gz', 'md5': 'a859915fc476b8ac9557573b992b1991', 'size': '1171094328'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818845/SRR17818845_2.fastq.gz', 'md5': '7adcbd4e691891ea751c8bf087fbf7fa', 'size': '1518473813'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818846,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818846/SRR17818846_1.fastq.gz', 'md5': 'df571f4d31582a7f31c8b115425a7151', 'size': '1056779424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818846/SRR17818846_2.fastq.gz', 'md5': '966933ae0cbbb7b9015fa9674a4d8be0', 'size': '1687636860'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818847,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818847/SRR17818847_1.fastq.gz', 'md5': '062adb6fef35e0e79d70ccea56ff0e34', 'size': '218409188'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818847/SRR17818847_2.fastq.gz', 'md5': '2d82eae5e797c920f0ecb34bae4389f5', 'size': '372008413'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818848,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818848/SRR17818848_1.fastq.gz', 'md5': '79e034e8e59bd739b7d6f34b49de5109', 'size': '1165822918'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818848/SRR17818848_2.fastq.gz', 'md5': '7bf893ad4d2e1b28b1c3b40a4e44f319', 'size': '1479211787'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818849,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818849/SRR17818849_1.fastq.gz', 'md5': 'e665e74a67bea1785881eff5bfcf7710', 'size': '1048194424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818849/SRR17818849_2.fastq.gz', 'md5': '09204b4f701f7d707c47845995013395', 'size': '1615775156'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818850,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818850/SRR17818850_1.fastq.gz', 'md5': '4384a2ae3ea39b866f4fc8a676287ead', 'size': '293645956'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818850/SRR17818850_2.fastq.gz', 'md5': 'e167fb040771554e3b0e48ae022e4b15', 'size': '494521721'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818851,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818851/SRR17818851_1.fastq.gz', 'md5': 'bdb4e9379dc8e0cdde7a44668099b9aa', 'size': '1169386584'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818851/SRR17818851_2.fastq.gz', 'md5': '09dcaa9d1c7b911c5b9587fa6eaf778d', 'size': '1490895024'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818852,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818852/SRR17818852_1.fastq.gz', 'md5': 'c5dd58d675105f61960c34238bcaef46', 'size': '1170207937'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818852/SRR17818852_2.fastq.gz', 'md5': '231419e66c5c463e8c1f246edacd753f', 'size': '1507227458'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818853,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818853/SRR17818853_1.fastq.gz', 'md5': '8be959819ea038e8277bd99a439b5a52', 'size': '1052491592'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818853/SRR17818853_2.fastq.gz', 'md5': '3b20bfa8f701157e76a88bf7d5a20c5b', 'size': '1669598094'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818854,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818854/SRR17818854_1.fastq.gz', 'md5': '8fa829aa61cd253aaba9fbe9a000691d', 'size': '243967872'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818854/SRR17818854_2.fastq.gz', 'md5': 'e490c1305bcacf0c88e28a3e08b8b38c', 'size': '413428286'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818855,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818855/SRR17818855_1.fastq.gz', 'md5': '24918f0beed5fcefa61b5db225b6f7a1', 'size': '1168498680'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818855/SRR17818855_2.fastq.gz', 'md5': '31c6be4ba77e4f93a0f335839314256c', 'size': '1485439187'}]",mouse PDX sample,Wild type,,,,210135734,17344283747,,,
SRR17818859,SRX13980725,NextSeq 500 paired end sequencing; GSM5848692: MSK72117-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818048,MSK72117-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848692: MSK72117-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17818859/SRR17818859.fastq.gz', 'md5': 'd81d8b7c4272f8b86897d914b9daadf4', 'size': '3990568788'}]",mouse PDX sample,Wild type,,,,113818653,6260025915,,,
SRR17818860,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818860/SRR17818860.fastq.gz', 'md5': 'e0dc2b6cf88a949241396bda7748cff6', 'size': '6294867736'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818861,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818861/SRR17818861.fastq.gz', 'md5': '17dd0b8d46512b03a9fc31506ee559b6', 'size': '6293480037'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818862,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818862/SRR17818862.fastq.gz', 'md5': '04b65e622518b33a7e59e42c0ce20f4d', 'size': '6343960026'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818860,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818860/SRR17818860.fastq.gz', 'md5': 'e0dc2b6cf88a949241396bda7748cff6', 'size': '6294867736'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818861,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818861/SRR17818861.fastq.gz', 'md5': '17dd0b8d46512b03a9fc31506ee559b6', 'size': '6293480037'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818862,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818862/SRR17818862.fastq.gz', 'md5': '04b65e622518b33a7e59e42c0ce20f4d', 'size': '6343960026'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818863,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/063/SRR17818863/SRR17818863.fastq.gz', 'md5': '059248ce747ca440339e136a9a0f688c', 'size': '6346907658'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818864,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818864/SRR17818864_1.fastq.gz', 'md5': '19473928eeb7aa5e8fb75c6618dccd3a', 'size': '1041390659'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818864/SRR17818864_2.fastq.gz', 'md5': 'c38e5e370931235e64976c6c9aeb13b7', 'size': '1428881618'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818865,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818865/SRR17818865_1.fastq.gz', 'md5': 'fc60671186ded38f1b80730388740ae6', 'size': '1053206339'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818865/SRR17818865_2.fastq.gz', 'md5': '6562420f3468cd2ab07ccee90bc37327', 'size': '1426419580'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818866,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/066/SRR17818866/SRR17818866_1.fastq.gz', 'md5': 'b39e4c0e55692aed914f58e55c2a3651', 'size': '1051244018'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/066/SRR17818866/SRR17818866_2.fastq.gz', 'md5': '06f023e1d5dac89cb896e0c0289d2c3b', 'size': '1434426125'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818867,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/067/SRR17818867/SRR17818867_1.fastq.gz', 'md5': '6024a89aeda6100fb3ced56e0a20c9cd', 'size': '768078165'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/067/SRR17818867/SRR17818867_2.fastq.gz', 'md5': 'd9a2bce0c609a9cd7078b89538ba8ccd', 'size': '1408208588'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818868,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/068/SRR17818868/SRR17818868_1.fastq.gz', 'md5': 'b6ca010adc9ffd013a92b6b555f60743', 'size': '1039946183'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/068/SRR17818868/SRR17818868_2.fastq.gz', 'md5': 'fc64ba97f47a98734b4bf515f0de85eb', 'size': '1437475418'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818869,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/069/SRR17818869/SRR17818869_1.fastq.gz', 'md5': '3a22ada4f302d77f772e7a65b96e41f6', 'size': '800417173'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/069/SRR17818869/SRR17818869_2.fastq.gz', 'md5': '3f19cd29cddf0caee6f49add4b562a21', 'size': '1489787119'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818870,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818870/SRR17818870_1.fastq.gz', 'md5': '1f34f22ff8252bb23b414092047db65d', 'size': '1045492188'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818870/SRR17818870_2.fastq.gz', 'md5': 'a81bc718bcf80e6c3534c688baaffe13', 'size': '1473585013'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818871,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818871/SRR17818871_1.fastq.gz', 'md5': '4980a66e1e32a80bd72a6374d6c18c15', 'size': '1043336720'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818871/SRR17818871_2.fastq.gz', 'md5': '03b6b1b056e32c6c23d4695e78d0daa8', 'size': '1482218658'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818872,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818872/SRR17818872_1.fastq.gz', 'md5': 'ecee14e99bcb0c4c76b6952d72b18a07', 'size': '741582761'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818872/SRR17818872_2.fastq.gz', 'md5': '6809b6f0dc97f1261643ae074e740405', 'size': '1430862706'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818873,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818873/SRR17818873_1.fastq.gz', 'md5': '6f939e0625f57a0700219bf679a0bc98', 'size': '1048015601'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818873/SRR17818873_2.fastq.gz', 'md5': 'f9cc6bfc39c635be2a84cb1e04df1825', 'size': '1459590559'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818874,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818874/SRR17818874_1.fastq.gz', 'md5': '95f8b525ae1e6a68f24134233c9be851', 'size': '1045959334'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818874/SRR17818874_2.fastq.gz', 'md5': 'a7dc5afdb6a09fcd58c212f27f21577d', 'size': '1470477612'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818875,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818875/SRR17818875_1.fastq.gz', 'md5': '4bbc3abde8a10825a49262b36367a857', 'size': '652526349'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818875/SRR17818875_2.fastq.gz', 'md5': '4ce030c0705726c88a4c8672cbe8c72f', 'size': '1272279109'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818876,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818876/SRR17818876_1.fastq.gz', 'md5': 'e7ed2a420c214ab60e9cddda25e0258a', 'size': '1140281102'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818876/SRR17818876_2.fastq.gz', 'md5': 'f9f3a5cecf9a5a494b108137139cf249', 'size': '1365548809'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818877,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818877/SRR17818877_1.fastq.gz', 'md5': 'e2853c63314e9341a951a0187ccf1127', 'size': '1147668386'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818877/SRR17818877_2.fastq.gz', 'md5': 'fbafe58fd84f2e72d20990e79044e4d9', 'size': '1394640229'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818878,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818878/SRR17818878_1.fastq.gz', 'md5': '11b2d8c4d6f97cda8b1115877c56c17d', 'size': '1061557422'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818878/SRR17818878_2.fastq.gz', 'md5': '2d1a41c323728a7db40236be8b10e435', 'size': '1475102218'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818879,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818879/SRR17818879_1.fastq.gz', 'md5': '5d7338102a5f5ffc58a4295ec1076112', 'size': '180107559'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818879/SRR17818879_2.fastq.gz', 'md5': '382a17d7e869e2ac10a5b89bd8a13b8c', 'size': '299590094'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818880,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818880/SRR17818880_1.fastq.gz', 'md5': 'd2dcd94b61c0513516e468e1717f7ca0', 'size': '1147507906'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818880/SRR17818880_2.fastq.gz', 'md5': '79adc0502405c96d040e1f02ef7d1136', 'size': '1394963068'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818881,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818881/SRR17818881_1.fastq.gz', 'md5': 'e7c7e5748b92f943d335c8d853abb6ec', 'size': '1148956758'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818881/SRR17818881_2.fastq.gz', 'md5': '97881d0b2b35949fc5664b54ade189f7', 'size': '1400773926'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818882,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818882/SRR17818882_1.fastq.gz', 'md5': 'd1a500cf4364850f1fda425a142f7621', 'size': '1063381216'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818882/SRR17818882_2.fastq.gz', 'md5': 'b1ed971965e79f6efcd686769df6a505', 'size': '1499859708'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818883,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818883/SRR17818883_1.fastq.gz', 'md5': 'c1b4a1e64f759c9ba51abb68cec86c28', 'size': '152523800'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818883/SRR17818883_2.fastq.gz', 'md5': 'e41481b1bcce02c333a7fbd7cd09d49a', 'size': '254192819'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818884,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818884/SRR17818884_1.fastq.gz', 'md5': '068da6ab3a1bf2744318877e3d45cd67', 'size': '1141721338'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818884/SRR17818884_2.fastq.gz', 'md5': '72bf3b783976b00e708e6c017d8bb4ea', 'size': '1371739210'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818885,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818885/SRR17818885_1.fastq.gz', 'md5': '04bf8701cd6d016d259cf55815a5e43f', 'size': '1056458320'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818885/SRR17818885_2.fastq.gz', 'md5': '4c1cf025e1704ef5291438e2d6921f0c', 'size': '1441258710'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818886,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/086/SRR17818886/SRR17818886_1.fastq.gz', 'md5': '116b113bd7ff6e6d853bf56ed75984a4', 'size': '195609107'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/086/SRR17818886/SRR17818886_2.fastq.gz', 'md5': 'c16596ceb6e507ec8cf88e9cf0f99611', 'size': '323419880'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818887,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/087/SRR17818887/SRR17818887_1.fastq.gz', 'md5': '496a60f1fbefd0249a536e7bac2a6e34', 'size': '1142918124'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/087/SRR17818887/SRR17818887_2.fastq.gz', 'md5': '4481a3d2f6b733c28a864265e21aec3d', 'size': '1386436484'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818888,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/088/SRR17818888/SRR17818888_1.fastq.gz', 'md5': 'af8657d1f8608e755ea84104f5182348', 'size': '1144161782'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/088/SRR17818888/SRR17818888_2.fastq.gz', 'md5': '4d5f9cd3526b5fc2761b5fe3a4d153e7', 'size': '1392054835'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818889,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/089/SRR17818889/SRR17818889_1.fastq.gz', 'md5': '221d5fa78ffee07c6a3f5370481fee3b', 'size': '1057384378'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/089/SRR17818889/SRR17818889_2.fastq.gz', 'md5': '58332cfd2895d48229062500b1e5c009', 'size': '1486519240'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818890,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/090/SRR17818890/SRR17818890_1.fastq.gz', 'md5': '27c6361b0e50f4c6dc735bc143d49131', 'size': '165816086'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/090/SRR17818890/SRR17818890_2.fastq.gz', 'md5': '4645deb7babb9cd0eff32550f1e35db3', 'size': '277111239'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818891,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/091/SRR17818891/SRR17818891_1.fastq.gz', 'md5': 'a7fb45599e98a26d7ee94141a00badae', 'size': '1145925727'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/091/SRR17818891/SRR17818891_2.fastq.gz', 'md5': '8e9e857c7e4013c648b5afb9459a6f9b', 'size': '1387669981'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818892,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/092/SRR17818892/SRR17818892_1.fastq.gz', 'md5': '9492d33346415700193604ea1716e058', 'size': '1097294647'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/092/SRR17818892/SRR17818892_2.fastq.gz', 'md5': '2880427bb0d2266201292552de70770c', 'size': '1255751822'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818893,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/093/SRR17818893/SRR17818893_1.fastq.gz', 'md5': 'f8b7e9a9037d3f74c797f90c5d2603d4', 'size': '1107583455'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/093/SRR17818893/SRR17818893_2.fastq.gz', 'md5': '43314d4be2422acf19cb511eaf1ba983', 'size': '1286499493'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818894,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/094/SRR17818894/SRR17818894_1.fastq.gz', 'md5': 'aaf3c8ccbd10cd953e411e72db404e83', 'size': '1050213863'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/094/SRR17818894/SRR17818894_2.fastq.gz', 'md5': 'ab6f1a4e20d924275116122623091b48', 'size': '1341593546'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818895,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/095/SRR17818895/SRR17818895_1.fastq.gz', 'md5': '56425a943400af7f0989484daa658344', 'size': '154651162'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/095/SRR17818895/SRR17818895_2.fastq.gz', 'md5': '03c22912f6db48a657b4843fe0c92a42', 'size': '258759095'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818896,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/096/SRR17818896/SRR17818896_1.fastq.gz', 'md5': 'a8a5322162dd79dee1ce1d356aee2f9b', 'size': '1040744850'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/096/SRR17818896/SRR17818896_2.fastq.gz', 'md5': '9c5e92795e34aba07ba6fd0c5ccc6fe2', 'size': '1307682149'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818897,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/097/SRR17818897/SRR17818897_1.fastq.gz', 'md5': 'ef19649458423ed9b4ee7cf59ea4ea05', 'size': '155058503'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/097/SRR17818897/SRR17818897_2.fastq.gz', 'md5': '2563bf21eca01e170a1fbdc392368cd7', 'size': '257545865'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818898,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/098/SRR17818898/SRR17818898_1.fastq.gz', 'md5': '80d4eb9a57f9b2fcf11369591724f14c', 'size': '1097488508'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/098/SRR17818898/SRR17818898_2.fastq.gz', 'md5': '4e8df43f7cc315d1f705a932aa6e57d6', 'size': '1275963595'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818899,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/099/SRR17818899/SRR17818899_1.fastq.gz', 'md5': '7697b943065a30232d07fe7f9672ccf4', 'size': '1039896383'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/099/SRR17818899/SRR17818899_2.fastq.gz', 'md5': '93ec583750dde510b34be1c1a10aab32', 'size': '1330896526'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818900,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/000/SRR17818900/SRR17818900_1.fastq.gz', 'md5': '9f0502a7f940b6507fb4efdf96e50d68', 'size': '160452217'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/000/SRR17818900/SRR17818900_2.fastq.gz', 'md5': '06038f670fe53070b5e3a4fcd1e6848d', 'size': '270268529'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818901,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/001/SRR17818901/SRR17818901_1.fastq.gz', 'md5': 'c13b17ad96afccbb50ed864107e04bf0', 'size': '1106358802'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/001/SRR17818901/SRR17818901_2.fastq.gz', 'md5': 'bece7576a0dc7d696bee7265caae2c40', 'size': '1277820179'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818902,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/002/SRR17818902/SRR17818902_1.fastq.gz', 'md5': '01719000efc5153ff83eb577f23ca857', 'size': '1049472689'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/002/SRR17818902/SRR17818902_2.fastq.gz', 'md5': 'b24d024cddd2326d54bc1f936b368f98', 'size': '1340443737'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818903,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/003/SRR17818903/SRR17818903_1.fastq.gz', 'md5': 'f96aac86006237d287e75336be1c8ba7', 'size': '131872702'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/003/SRR17818903/SRR17818903_2.fastq.gz', 'md5': '31a4b70a10e38699510bd5bfab897c09', 'size': '219744114'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818904,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/004/SRR17818904/SRR17818904.fastq.gz', 'md5': '8516b1b08c61b99a0362526de4bda8b1', 'size': '3242428293'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818905,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/005/SRR17818905/SRR17818905.fastq.gz', 'md5': '6c70d0cb367ee83db715bcd5c5f28276', 'size': '3249187050'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818906,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/006/SRR17818906/SRR17818906.fastq.gz', 'md5': 'e491d1dfa6ba3622097423abd236c107', 'size': '3200218491'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818907,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/007/SRR17818907/SRR17818907.fastq.gz', 'md5': '8978f0b39d0708984ebadd23ef62f372', 'size': '3220543408'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818908,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/008/SRR17818908/SRR17818908.fastq.gz', 'md5': '4d9609498b0f3f84d9643c3bfb19ada5', 'size': '5549303802'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818909,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/009/SRR17818909/SRR17818909.fastq.gz', 'md5': '964a3323b1bc44cf9dfc2c13c052a32c', 'size': '5616829106'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818910,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/010/SRR17818910/SRR17818910.fastq.gz', 'md5': '28276c04cb9aba0cdf8e5a2a3dd249c6', 'size': '5611019004'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818911,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/011/SRR17818911/SRR17818911.fastq.gz', 'md5': '4a3865573ab25647284d54be8d0491e7', 'size': '5685413352'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818912,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/012/SRR17818912/SRR17818912_1.fastq.gz', 'md5': '2954e1a663e5059b2748642c013686f8', 'size': '1146378392'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/012/SRR17818912/SRR17818912_2.fastq.gz', 'md5': '80047033df33ca9c7777ee1cbd10fd1d', 'size': '1641821516'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818913,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/013/SRR17818913/SRR17818913_1.fastq.gz', 'md5': '5338160248105b8742df5265f5078e14', 'size': '1152026112'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/013/SRR17818913/SRR17818913_2.fastq.gz', 'md5': '9f478db48aacbc099556c2398b377fd5', 'size': '1689981968'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818914,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/014/SRR17818914/SRR17818914_1.fastq.gz', 'md5': 'd32ffad176a6092a629f847570a83dbd', 'size': '841952946'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/014/SRR17818914/SRR17818914_2.fastq.gz', 'md5': '4db6414fbf7b7d441e07fe326282ae47', 'size': '1851014823'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818915,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/015/SRR17818915/SRR17818915_1.fastq.gz', 'md5': '630fddfa811ea9c40e7574ca84ac80d5', 'size': '1158624706'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/015/SRR17818915/SRR17818915_2.fastq.gz', 'md5': 'ec1183602792ed2ca968363dbeeb0b3f', 'size': '1668062923'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818916,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/016/SRR17818916/SRR17818916_1.fastq.gz', 'md5': 'e615fc263ad9d9e46866b02b4345d2d8', 'size': '1145123320'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/016/SRR17818916/SRR17818916_2.fastq.gz', 'md5': '504e2a2be96f88774e5b13f7348e2598', 'size': '1647757155'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818917,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/017/SRR17818917/SRR17818917_1.fastq.gz', 'md5': 'dc452f63e1b94797c0048a3af7c03c44', 'size': '990726504'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/017/SRR17818917/SRR17818917_2.fastq.gz', 'md5': '8219a6799879917c2f30fe649e88bba0', 'size': '1978019787'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818918,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/018/SRR17818918/SRR17818918_1.fastq.gz', 'md5': '97a0f9ca2e602a6794694615c60f6264', 'size': '164888085'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/018/SRR17818918/SRR17818918_2.fastq.gz', 'md5': '974348485ad76bf70ac82847b27cac90', 'size': '323280281'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818919,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/019/SRR17818919/SRR17818919_1.fastq.gz', 'md5': 'df1f38499c832ec9471187be5512ce16', 'size': '1149322556'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/019/SRR17818919/SRR17818919_2.fastq.gz', 'md5': '98fe4a3c0ec589ec4f84b2e62e969603', 'size': '1634606559'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818920,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/020/SRR17818920/SRR17818920_1.fastq.gz', 'md5': '7fa009abae7ec44d30655721c776b828', 'size': '1147871524'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/020/SRR17818920/SRR17818920_2.fastq.gz', 'md5': '50fc9500117face3b381c2f099ba71c4', 'size': '1640482425'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818921,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/021/SRR17818921/SRR17818921_1.fastq.gz', 'md5': '3206a2d150a51049fec673abd1ee1aee', 'size': '1001203533'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/021/SRR17818921/SRR17818921_2.fastq.gz', 'md5': 'c8c0a44e5349d45ea575fd3f994e6529', 'size': '1934623256'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818922,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/022/SRR17818922/SRR17818922_1.fastq.gz', 'md5': '385993497b34701d6f03be0e936a80d7', 'size': '187857805'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/022/SRR17818922/SRR17818922_2.fastq.gz', 'md5': 'b219d6fb887c85092e49551af0b1b5bb', 'size': '361200105'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818923,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/023/SRR17818923/SRR17818923_1.fastq.gz', 'md5': '3b54946e50fd5df16ff7848ba0f6e635', 'size': '1155735055'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/023/SRR17818923/SRR17818923_2.fastq.gz', 'md5': 'aca9fd557254ea2c33612503cd2c8a39', 'size': '1684832189'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818936,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818936/SRR17818936_1.fastq.gz', 'md5': '6f16b7b934b3bdc96266c823664f08bc', 'size': '1155184640'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818936/SRR17818936_2.fastq.gz', 'md5': '44d8b6842b814238d9777e6efa6eadb9', 'size': '1670557227'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818937,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818937/SRR17818937_1.fastq.gz', 'md5': '141930a9c3b8d42c43dd3defc063f136', 'size': '903403599'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818937/SRR17818937_2.fastq.gz', 'md5': 'a6b209d8192733949c034c9611ae1297', 'size': '1870133755'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818924,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/024/SRR17818924/SRR17818924_1.fastq.gz', 'md5': '5716d0657c4b8041b71be707cdf5327d', 'size': '1098431276'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/024/SRR17818924/SRR17818924_2.fastq.gz', 'md5': '43fb005c1491eb50f3c752c2aa38fd8a', 'size': '1264560816'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818925,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/025/SRR17818925/SRR17818925_1.fastq.gz', 'md5': '9218985552b09838d436e90b81ea6f2a', 'size': '1105647711'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/025/SRR17818925/SRR17818925_2.fastq.gz', 'md5': '0eedb41f1705648c47769cb74e6010be', 'size': '1258858502'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818926,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/026/SRR17818926/SRR17818926_1.fastq.gz', 'md5': '5ebae3eda7f2b8be80a6e5fadadb9178', 'size': '1049089219'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/026/SRR17818926/SRR17818926_2.fastq.gz', 'md5': 'b9e20f1d8a95f2a85fb5587afaba5031', 'size': '1308154415'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818927,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/027/SRR17818927/SRR17818927_1.fastq.gz', 'md5': '69a0a87a54ea4b76ebf3d186eefe2436', 'size': '177554932'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/027/SRR17818927/SRR17818927_2.fastq.gz', 'md5': 'dbd9e5a5e1e317e481adcad8afde4748', 'size': '290220812'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818928,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/028/SRR17818928/SRR17818928_1.fastq.gz', 'md5': '694b592774c079e6c1cda5968495345c', 'size': '1041152614'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/028/SRR17818928/SRR17818928_2.fastq.gz', 'md5': '0c751a7504844614a45a6020799155e6', 'size': '1306383716'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818929,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/029/SRR17818929/SRR17818929_1.fastq.gz', 'md5': '6c8edb87625ca51511bbc89ade7dd95d', 'size': '198163902'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/029/SRR17818929/SRR17818929_2.fastq.gz', 'md5': 'd32548144ba291759cd931b64481affe', 'size': '326477456'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818930,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/030/SRR17818930/SRR17818930_1.fastq.gz', 'md5': 'c443f9a3ec6ef8f0d745d6e2bf21ae22', 'size': '1097908613'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/030/SRR17818930/SRR17818930_2.fastq.gz', 'md5': '4e4ea5dd58c3aeb83ff92b560e7cc8bb', 'size': '1259411940'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818931,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/031/SRR17818931/SRR17818931_1.fastq.gz', 'md5': 'b22c3fba0db0a2a1a5151e3626a2f097', 'size': '1053085498'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/031/SRR17818931/SRR17818931_2.fastq.gz', 'md5': 'b3e5a3c0c6e656194e3e8d8ecbb73084', 'size': '1292373878'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818932,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/032/SRR17818932/SRR17818932_1.fastq.gz', 'md5': 'db3bfbf6f4a3afd0c4f8286306b13728', 'size': '216150345'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/032/SRR17818932/SRR17818932_2.fastq.gz', 'md5': '0d1067cf02448f3857109423250b5f36', 'size': '376930864'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818933,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/033/SRR17818933/SRR17818933_1.fastq.gz', 'md5': '76637f7591d8efd4c3c9db4149c90ea4', 'size': '1104924228'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/033/SRR17818933/SRR17818933_2.fastq.gz', 'md5': '84bf11e7f21e289f99533cd6ec2e2f0a', 'size': '1254322812'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818934,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/034/SRR17818934/SRR17818934_1.fastq.gz', 'md5': 'b29dff9a2d332011e77def7e11cb3d59', 'size': '1049033097'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/034/SRR17818934/SRR17818934_2.fastq.gz', 'md5': '92470c7297c3dcd2259075104d1f28e5', 'size': '1305372743'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818935,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/035/SRR17818935/SRR17818935_1.fastq.gz', 'md5': '1da3813f1c92c6054efe7e871d2d48ea', 'size': '169697630'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/035/SRR17818935/SRR17818935_2.fastq.gz', 'md5': '72f9a08d3dd6163742ab4d001214e89b', 'size': '276473511'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818938,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/038/SRR17818938/SRR17818938.fastq.gz', 'md5': '47307ed74d2ab8951f9b52cce5778e17', 'size': '5974378796'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818939,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/039/SRR17818939/SRR17818939.fastq.gz', 'md5': '33b54bc3b549c04c798de2bec21ed3f1', 'size': '6083016323'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818940,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818940/SRR17818940.fastq.gz', 'md5': '511ad7c5852558be2f8e01ed6922492b', 'size': '6045090995'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818941,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818941/SRR17818941.fastq.gz', 'md5': 'a19e08713e7eeaad3749c3d43c94e8fc', 'size': '6160774510'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818946,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818946/SRR17818946_1.fastq.gz', 'md5': '58c3121256eaee1894ba73bd22bd9579', 'size': '1055939202'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818946/SRR17818946_2.fastq.gz', 'md5': '88401ceb7fa7be3d58b4f9943108c8ac', 'size': '1222493390'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818947,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818947/SRR17818947_1.fastq.gz', 'md5': '26c5725d6a98c362dbe69ee650727289', 'size': '1057744499'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818947/SRR17818947_2.fastq.gz', 'md5': '0fd00a753a9d53e14d56bb8304d34cfb', 'size': '1229995412'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818948,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818948/SRR17818948_1.fastq.gz', 'md5': '01e422002239238ae1c3f2b98bb3436e', 'size': '1063177482'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818948/SRR17818948_2.fastq.gz', 'md5': '141cc967cb56671327870f57a335e54f', 'size': '1227402530'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818949,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818949/SRR17818949_1.fastq.gz', 'md5': '19726e9744a4d04a1ddf725a96ba3093', 'size': '1065406237'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818949/SRR17818949_2.fastq.gz', 'md5': 'c7d9ceddc16e2737d5aff8496d4cf0cf', 'size': '1240879047'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818950,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818950/SRR17818950_1.fastq.gz', 'md5': '1962645ca16ed37b458d0126ad7c4a4d', 'size': '843586235'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818950/SRR17818950_2.fastq.gz', 'md5': 'a7244e26757edf8d4e247b98214a8220', 'size': '1107098843'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818951,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818951/SRR17818951_1.fastq.gz', 'md5': '83dcd7fbbec5ee5e64ad09a1cfb277f7', 'size': '901510704'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818951/SRR17818951_2.fastq.gz', 'md5': '52965fe3f7a19c41603e5dcf22783feb', 'size': '1193114539'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818952,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818952/SRR17818952_1.fastq.gz', 'md5': '22cf62830a44c7265d67a13731953b5c', 'size': '824469894'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818952/SRR17818952_2.fastq.gz', 'md5': 'd024e854c1643df337cda58376ede9d1', 'size': '1078794933'}]",mouse PDX sample,Wild type,,,,,,,,
SRR17818953,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,2022-02-06,2022-02-06,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818953/SRR17818953_1.fastq.gz', 'md5': '1f675be396f7d6c411d465da5f1b89f1', 'size': '860181604'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818953/SRR17818953_2.fastq.gz', 'md5': 'c9aff929633524bad686f5d2c5687050', 'size': '1137345303'}]",mouse PDX sample,Wild type,,,,,,,,
SRR13268672,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/072/SRR13268672/SRR13268672_1.fastq.gz', 'md5': 'a21a676b839e29c51eafafd2f1f9ca19', 'size': '9269195879'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/072/SRR13268672/SRR13268672_2.fastq.gz', 'md5': 'd54b63bf4f576eaa5bc75dbcff927858', 'size': '8317206070'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268673,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/073/SRR13268673/SRR13268673_1.fastq.gz', 'md5': '15ff80bb6adc1b7f50cc51f692e218e2', 'size': '10724219181'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/073/SRR13268673/SRR13268673_2.fastq.gz', 'md5': 'd70474305d3d3b4c9dbeb7f20214312f', 'size': '9669556692'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268674,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/074/SRR13268674/SRR13268674_1.fastq.gz', 'md5': '489a2b8df86182a39151acf99656f104', 'size': '11086356893'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/074/SRR13268674/SRR13268674_2.fastq.gz', 'md5': 'c217b26ce6484a46e41ae60bc3c9ba5a', 'size': '9868311186'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268675,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/075/SRR13268675/SRR13268675_1.fastq.gz', 'md5': '68e9af2ea06fd983dc9a5683b4f7cf6d', 'size': '8812254038'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/075/SRR13268675/SRR13268675_2.fastq.gz', 'md5': 'ab9db16ca564cec4000382c70ef0fc73', 'size': '7868222739'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268676,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/076/SRR13268676/SRR13268676_1.fastq.gz', 'md5': 'ce141707de38cf3968610a09ff6df059', 'size': '8723966178'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/076/SRR13268676/SRR13268676_2.fastq.gz', 'md5': '5873395049196a73f7882facc6093e3d', 'size': '7679486242'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268677,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/077/SRR13268677/SRR13268677_1.fastq.gz', 'md5': '96ba05cb2bd18a44119241c48c0c6552', 'size': '10797332478'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/077/SRR13268677/SRR13268677_2.fastq.gz', 'md5': 'a6c159a20347f9a423296325be9a4dfe', 'size': '9492385555'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268678,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/078/SRR13268678/SRR13268678_1.fastq.gz', 'md5': '9bfe9b06c48b1a7656cf72740a409011', 'size': '10111032065'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/078/SRR13268678/SRR13268678_2.fastq.gz', 'md5': '66ee6e10b521093afb464e29a7569a5f', 'size': '8991128350'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268679,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/079/SRR13268679/SRR13268679_1.fastq.gz', 'md5': '32470ba435f4a115638001aaaddd325b', 'size': '8960864573'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/079/SRR13268679/SRR13268679_2.fastq.gz', 'md5': 'e8ba203349aa3c839690690b9d343217', 'size': '7886999110'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268680,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/080/SRR13268680/SRR13268680_1.fastq.gz', 'md5': 'fc0d7e84a9ac0d17c684ffde703af710', 'size': '8960435522'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/080/SRR13268680/SRR13268680_2.fastq.gz', 'md5': 'ac2dcd3668c272401bcbf86af0429165', 'size': '8047142349'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268681,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/081/SRR13268681/SRR13268681_1.fastq.gz', 'md5': '731c268066d8510e2c67efa64160c140', 'size': '10418903525'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/081/SRR13268681/SRR13268681_2.fastq.gz', 'md5': '12d6ce4a06eb0d9fc459c5029c4c4846', 'size': '9376729160'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268682,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/082/SRR13268682/SRR13268682_1.fastq.gz', 'md5': '80eed0810fd75f2652cfd9ec9595f732', 'size': '8269485424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/082/SRR13268682/SRR13268682_2.fastq.gz', 'md5': '893a5eddd49ddede4a8eb2dded5fbfe9', 'size': '7407106093'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268683,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/083/SRR13268683/SRR13268683_1.fastq.gz', 'md5': '6353aafadd128ce390baad9048fd1438', 'size': '10650492999'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/083/SRR13268683/SRR13268683_2.fastq.gz', 'md5': '10099d1cb36ced23a1f808beac022ab2', 'size': '9454472500'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268685,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/085/SRR13268685/SRR13268685_1.fastq.gz', 'md5': '693e1bff0ce4c6b98f1e849741fb1c3d', 'size': '9643195246'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/085/SRR13268685/SRR13268685_2.fastq.gz', 'md5': 'ee5150f4ea17cf567d00b1f7f6320b57', 'size': '8533529543'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268686,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/086/SRR13268686/SRR13268686_1.fastq.gz', 'md5': '1f253b64a0c4441e32106b67d8878e7f', 'size': '12859261817'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/086/SRR13268686/SRR13268686_2.fastq.gz', 'md5': 'bc99c14797355adcb9443debce37abb9', 'size': '11560630542'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268687,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/087/SRR13268687/SRR13268687_1.fastq.gz', 'md5': 'b090769646f7a3d9718abc85a813f99f', 'size': '6895670921'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/087/SRR13268687/SRR13268687_2.fastq.gz', 'md5': '19c77db589425067565ae075dfcfe50c', 'size': '6120826112'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268688,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/088/SRR13268688/SRR13268688_1.fastq.gz', 'md5': 'c28ece9f40320ea776b14a795cff14aa', 'size': '9689936086'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/088/SRR13268688/SRR13268688_2.fastq.gz', 'md5': 'e2857e8789e4ace85d153d7bb29dd3a5', 'size': '8764648737'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268689,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/089/SRR13268689/SRR13268689_1.fastq.gz', 'md5': '7c48acb355badef8ccd7d9d57756a5fd', 'size': '9966196287'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/089/SRR13268689/SRR13268689_2.fastq.gz', 'md5': '651bee7272360e978d7e4dc79552216e', 'size': '8827326000'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268690,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/090/SRR13268690/SRR13268690_1.fastq.gz', 'md5': 'bb8906736a75d83e056ad81d63579121', 'size': '10707693136'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/090/SRR13268690/SRR13268690_2.fastq.gz', 'md5': '2ee7986d5bd0195651780676bc03f3a0', 'size': '9422966923'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268691,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/091/SRR13268691/SRR13268691_1.fastq.gz', 'md5': '09ac4ed0368b068f77379774c577c0b7', 'size': '8024786343'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/091/SRR13268691/SRR13268691_2.fastq.gz', 'md5': 'f7989487f4d093e683350b640d6fc369', 'size': '7095423738'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268692,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/092/SRR13268692/SRR13268692_1.fastq.gz', 'md5': '640e921722e085834096d8226498a863', 'size': '9065972139'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/092/SRR13268692/SRR13268692_2.fastq.gz', 'md5': 'cf4f043baa0fdcd06e01cd5da8f0124b', 'size': '8024800927'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268693,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/093/SRR13268693/SRR13268693_1.fastq.gz', 'md5': '58ecfdb2f170980ee676e1d3557bbc65', 'size': '10885732716'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/093/SRR13268693/SRR13268693_2.fastq.gz', 'md5': 'fb0cceacb09446d3019dc5e903665d2c', 'size': '9533097330'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268694,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/094/SRR13268694/SRR13268694_1.fastq.gz', 'md5': '07e91961faad6405739d81d17c1ee954', 'size': '9039052126'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/094/SRR13268694/SRR13268694_2.fastq.gz', 'md5': '2abbd5cc294a3eb3b14260e2d16062c2', 'size': '7910397241'}]",,,,,tendon,,,,tendon injury site,C57B6
SRR13268695,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,2021-05-02,2021-05-02,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/095/SRR13268695/SRR13268695_1.fastq.gz', 'md5': '350111c70ae4a323728a2a14cc21656c', 'size': '8950010625'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/095/SRR13268695/SRR13268695_2.fastq.gz', 'md5': 'b134a0c81aee78d87dd9f8ae9ea1b27f', 'size': '7828048144'}]",,,,,tendon,,,,tendon injury site,C57B6
